title: Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
abstract: Several molecules that suppress metastasis without suppressing tumorigenicity have been identified, but their mechanisms of action have not yet been determined. Many block growth at the secondary site, suggesting involvement in how cells respond to signals from the extracellular milieu. Breast cancer metastasis suppressor 1 (BRMS1)-transfected MDA-MB-435 cells were examined for modifications of phosphoinositide signaling as a potential mechanism for metastasis suppression. 435/BRMS1 cells expressed <10% of phosphatidylinositol-4, 5-bisphosphate compared with parental cells, whereas levels of the PtdIns(4)P and phosphatidylinositol-3-phosphate were unchanged. Inositol (1,4,5)-trisphosphate [Ins(1,4,5)P(3)] were decreased in 435/BRMS1 cells by approximately 50%. Phosphatidylinositol-3,4,5-trisphosphate levels were undetectable in 435/BRMS1 cells, even when stimulated by exogenous insulin or platelet-derived growth factor. Immunofluorescence microscopy to examine cellular distribution confirmed that phosphatidylinositol-4,5-bisphosphate distribution with cells was unchanged but was uniformly decreased throughout the cell. Although the gross morphology of 435/BRMS1 cells is similar to the parent, filamentous actin was more readily apparent in 435/BRMS1. Intracellular calcium, measured using Fluo-3 and Fura-2 fluorescent calcium indicator dyes, was somewhat lower, but not statistically different in 435/BRMS1 compared with parental cell. However, when stimulated with platelet-derived growth factor, MDA-MB-435 cells, but not 435/BRMS1 cells mobilized intracellular calcium. Taken together, these results implicate signaling through phosphoinositides in the regulation of breast cancer metastasis, specifically metastasis that can be suppressed by BRMS1.
authors.affiliation: Department of Biology, Utah State University, Logan, UT, USA. dewald@biology.usu.edu
authors.forename: Daryll B
authors.initials: DB
authors.lastname: DeWald
authors.forename: Javad
authors.initials: J
authors.lastname: Torabinejad
authors.forename: Rajeev S
authors.initials: RS
authors.lastname: Samant
authors.forename: Derrick
authors.initials: D
authors.lastname: Johnston
authors.forename: Nuray
authors.initials: N
authors.lastname: Erin
authors.forename: Joseph C
authors.initials: JC
authors.lastname: Shope
authors.forename: Yi
authors.initials: Y
authors.lastname: Xie
authors.forename: Danny R
authors.initials: DR
authors.lastname: Welch
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D006801:Humans; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D010716:Phosphatidylinositols / Q000378:metabolism / Q000502:physiology*; D012097:Repressor Proteins; D015398:Signal Transduction / Q000502:physiology; D014162:Transfection
chemical_list: C410024:BRMS1 protein, human; D009363:Neoplasm Proteins; D010716:Phosphatidylinositols; D012097:Repressor Proteins